Multivariate analysis | ||||
---|---|---|---|---|
Outcome parameter | Univariate analysis (P) | P | Odds ratio | 95% confidence interval |
Morbidity | ||||
Diagnosis | 0.02* | 0.27 | 0.38 | 0.05–2.34 |
Resection type | 0.02† | 0.08 | 0.30 | 0.07–1.28 |
Operation time | 0.01 | 0.23 | 1.00 | 0.99–1.00 |
Mortality (operation time) | 0.02 | 0.04 | 0.99 | 0.99–1.00 |
Liver failure | ||||
Uptake | 0.01 | 0.03 | 3.96 | 1.17–13.4 |
Diagnosis | 0.04* | 0.36 | 0.37 | 0.04–3.12 |
Liver failure–related mortality | ||||
Uptake | 0.02 | 0.19 | 80.8 | 0.12–53,700 |
Diagnosis | 0.04* | 0.40 | 102 | 0.00–44,200 |
Operation time | 0.01 | 0.27 | 0.96 | 0.89–1.04 |
↵* Hilar cholangiocarcinoma patients were compared with other patients combined.
↵† (Extended) hemihepatectomy patients were compared with other patients combined.
Factors that were evaluated in univariate analysis were 99mTc-mebrofenin uptake, age, sex, diagnosis, chronic liver disease, resection type, operation time, blood loss, preoperative aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, albumin, bilirubin, alkaline phosphatase, γ-glutamyl transferase, prothrombin time, activated partial thromboplastin time, antithrombin III, and ICG clearance rate. Only significant factors in univariate analysis are shown.